Barbara Zhizhen Zheng (Barbara Zheng)

Years Active: 2020-2022
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Kyle Parcella, Tao Wang, Kyle Eastman, Zhongxing Zhang, Zhiwei Yin, Manoj Patel, Yong Tu, Barbara Zhizhen Zheng, Michael A Walker, Mark G Saulnier, David Frennesson, Michael Bowsher, Eric Gillis, Kevin M Peese, Makonen Belema, Christopher Cianci, Ira B Dicker, Brian McAuliffe, Bo Ding, Paul Falk, Jean Simmermacher, Dawn D Parker, Prasanna Sivaprakasam, Kevin Kish, Hal Lewis, Umesh Hanumegowda, Susan Jenkins, John F Kadow, Mark Krystal, Nicholas A Meanwell, B Narasimhulu Naidu
Discovery and Preclinical Profiling of GSK3839919, a Potent HIV-1 Allosteric Integrase Inhibitor. ACS medicinal chemistry letters 13 (6) (2022)
Li-Qiang Sun, Eric Mull, Stanley D'Andrea, Barbara Zhizhen Zheng, Sheldon Hiebert, Eric Gillis, Michael Bowsher, Sarkunam Kandhasamy, Venkata Rao Baratam, Sunitha Puttaswamy, Nagalakshmi Pulicharla, Sureshbabu Vishwakrishnan, Subba Reddy, Ravi Trivedi, Sarmistha Sinha, Sankar Sivaprasad, Abhijith Rao, Salil Desai, Kaushik Ghosh, Rushith Anumula, Amit Kumar, Ramkumar Rajamani, Ying-Kai Wang, Hua Fang, Arvind Mathur, Richard Rampulla, Tatyana A Zvyaga, Kathy Mosure, Susan Jenkins, Paul Falk, Debarati M Tagore, Chaoqun Chen, Kishore Rendunchintala, James Loy, Nicholas A Meanwell, Fiona McPhee, Paul M Scola
Discovery of BMS-986144, a Third-Generation, Pan-Genotype NS3/4A Protease Inhibitor for the Treatment of Hepatitis C Virus Infection. Journal of medicinal chemistry 63 (23) (2020)

Barbara Zhizhen Zheng.css-eqlu8i{font-size:small;padding-left:4px;} (Barbara Zheng)